Literature DB >> 17218713

When should antiretroviral therapy for HIV be started?

Andrew N Phillips1, Brian G Gazzard, Nathan Clumeck, Marcelo H Losso, Jens D Lundgren.   

Abstract

Mesh：

Year:  2007        PMID： 17218713      PMCID： PMC1767243          DOI： 10.1136/bmj.39064.406389.94

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  20 in total

Review 1.  When should antiretroviral therapy be started for HIV infection? Interpreting the evidence from observational studies.

Authors:  Andrew N Phillips; Alessandro Cozzi Lepri; Fiona Lampe; Margaret Johnson; Caroline A Sabin
Journal:  AIDS       Date:  2003-09-05       Impact factor: 4.177

2.  Reference ranges and sources of variability of CD4 counts in HIV-seronegative women and men.

Authors:  M K Maini; R J Gilson; N Chavda; S Gill; A Fakoya; E J Ross; A N Phillips; I V Weller
Journal:  Genitourin Med       Date:  1996-02

3.  Images in clinical medicine. Lipodystrophy associated with an HIV-protease inhibitor.

Authors:  A Carr; D A Cooper
Journal:  N Engl J Med       Date:  1998-10-29       Impact factor: 91.245

4.  Treat HIV-1 infection like other infections--treat it.

Authors:  B D Walker; N Basgoz
Journal:  JAMA       Date:  1998-07-01       Impact factor: 56.272

5.  The case for conservative management of early HIV disease.

Authors:  W J Burman; R R Reves; D L Cohn
Journal:  JAMA       Date:  1998-07-01       Impact factor: 56.272

6.  A syndrome of lipoatrophy, lactic acidaemia and liver dysfunction associated with HIV nucleoside analogue therapy: contribution to protease inhibitor-related lipodystrophy syndrome.

Authors:  A Carr; J Miller; M Law; D A Cooper
Journal:  AIDS       Date:  2000-02-18       Impact factor: 4.177

7.  Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies.

Authors:  Matthias Egger; Margaret May; Geneviève Chêne; Andrew N Phillips; Bruno Ledergerber; François Dabis; Dominique Costagliola; Antonella D'Arminio Monforte; Frank de Wolf; Peter Reiss; Jens D Lundgren; Amy C Justice; Schlomo Staszewski; Catherine Leport; Robert S Hogg; Caroline A Sabin; M John Gill; Bernd Salzberger; Jonathan A C Sterne
Journal:  Lancet       Date:  2002-07-13       Impact factor: 79.321

8.  The impact of episodic CD4 cell count-guided antiretroviral therapy on quality of life.

Authors:  William J Burman; Birgit Grund; Mollie P Roediger; Gerald Friedland; Janet Darbyshire; Albert W Wu
Journal:  J Acquir Immune Defic Syndr       Date:  2008-02-01       Impact factor: 3.731

9.  Combination antiretroviral therapy and the risk of myocardial infarction.

Authors:  Nina Friis-Møller; Caroline A Sabin; Rainer Weber; Antonella d'Arminio Monforte; Wafaa M El-Sadr; Peter Reiss; Rodolphe Thiébaut; Linda Morfeldt; Stephane De Wit; Christian Pradier; Gonzalo Calvo; Matthew G Law; Ole Kirk; Andrew N Phillips; Jens D Lundgren
Journal:  N Engl J Med       Date:  2003-11-20       Impact factor: 91.245

10.  Short-term risk of AIDS according to current CD4 cell count and viral load in antiretroviral drug-naive individuals and those treated in the monotherapy era.

Authors:  A Phillips; Patrizio Pezzotti
Journal:  AIDS       Date:  2004-01-02       Impact factor: 4.177
View more
  23 in total

1.  Inhibition of HIV-1 by a Lentiviral Vector with a Novel Tat-Inducible Expression System and a Specific Tropism to the Target Cells.

Authors:  Touraj Farazmandfar; Mohammad Reza Haghshenas; Majid Shahbazi
Journal:  Hum Gene Ther       Date:  2015-08-06       Impact factor: 5.695

2.  Children and Human Immunodeficiency Virus Infection: Opportunities and challenges.

Authors:  Moeness M Al-Shishtawy
Journal:  Sultan Qaboos Univ Med J       Date:  2014-10-14

3.  Understanding people who have never received HIV medical care: a population-based approach.

Authors:  Jennifer L Fagan; Jeanne Bertolli; A D McNaghten
Journal:  Public Health Rep       Date:  2010 Jul-Aug       Impact factor: 2.792

4.  Immunodeficiency at the start of combination antiretroviral therapy in low-, middle-, and high-income countries.

Authors:  Dorita Avila; Keri N Althoff; Catrina Mugglin; Kara Wools-Kaloustian; Manuel Koller; François Dabis; Denis Nash; Thomas Gsponer; Somnuek Sungkanuparph; Catherine McGowan; Margaret May; David Cooper; Cleophas Chimbetete; Marcelo Wolff; Ann Collier; Hamish McManus; Mary-Ann Davies; Dominique Costagliola; Brenda Crabtree-Ramirez; Romanee Chaiwarith; Angela Cescon; Morna Cornell; Lameck Diero; Praphan Phanuphak; Adrien Sawadogo; Jochen Ehmer; Serge P Eholie; Patrick C K Li; Matthew P Fox; Neel R Gandhi; Elsa González; Christopher K C Lee; Christopher J Hoffmann; Andrew Kambugu; Olivia Keiser; Rossana Ditangco; Hans Prozesky; Fiona Lampe; Nagalingeswaran Kumarasamy; Mari Kitahata; Emmanuel Lugina; Rita Lyamuya; Saphonn Vonthanak; Valeria Fink; Antonella d'Arminio Monforte; Paula Mendes Luz; Yi-Ming A Chen; Albert Minga; Jordi Casabona; Albert Mwango; Jun Y Choi; Marie-Louise Newell; Elizabeth A Bukusi; Kapella Ngonyani; Tuti P Merati; Juliana Otieno; Mwebesa B Bosco; Sam Phiri; Oon T Ng; Kathryn Anastos; Jürgen Rockstroh; Ignacio Santos; Shinichi Oka; Geoffrey Somi; Christoph Stephan; Ramon Teira; Deo Wabwire; Gilles Wandeler; Andrew Boulle; Peter Reiss; Robin Wood; Benjamin H Chi; Carolyn Williams; Jonathan A Sterne; Matthias Egger
Journal:  J Acquir Immune Defic Syndr       Date:  2014-01-01       Impact factor: 3.731

5.  Initiating patients on antiretroviral therapy at CD4 cell counts above 200 cells/microl is associated with improved treatment outcomes in South Africa.

Authors:  Matthew P Fox; Ian M Sanne; Francesca Conradie; Jennifer Zeinecker; Catherine Orrell; Prudence Ive; Mohammed Rassool; Marjorie Dehlinger; Charles van der Horst; James McIntyre; Robin Wood
Journal:  AIDS       Date:  2010-08-24       Impact factor: 4.177

6.  Long-term increase in CD4+ T-cell counts during combination antiretroviral therapy for HIV-1 infection.

Authors:  Judith J Lok; Ronald J Bosch; Constance A Benson; Ann C Collier; Gregory K Robbins; Robert W Shafer; Michael D Hughes
Journal:  AIDS       Date:  2010-07-31       Impact factor: 4.177

Review 7.  HIV infection.

Authors:  Martin Talbot
Journal:  BMJ Clin Evid       Date:  2008-07-31

8.  The therapeutic implications of timely linkage and early retention in HIV care.

Authors:  Kimberly B Ulett; James H Willig; Hui-Yi Lin; Justin S Routman; Sarah Abroms; Jeroan Allison; Ashlee Chatham; James L Raper; Michael S Saag; Michael J Mugavero
Journal:  AIDS Patient Care STDS       Date:  2009-01       Impact factor: 5.078

9.  When to start antiretroviral therapy in resource-limited settings: a human rights analysis.

Authors:  Nathan Ford; Alexandra Calmy; Samia Hurst
Journal:  BMC Int Health Hum Rights       Date:  2010-03-31

Review 10.  Genetic therapies against HIV.

Authors:  John J Rossi; Carl H June; Donald B Kohn
Journal:  Nat Biotechnol       Date:  2007-12       Impact factor: 54.908
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.